Haematopoietic stem and progenitor cells (HSPCs) maintain the vertebrate blood system throughout life and their emergence from haemogenic endothelium (HE) is tightly regulated by transcription factors such as Gata2. Zebrafish have two orthologues of Gata2, gata2a and gata2b, the latter required for HSPC emergence. Here we deleted a conserved enhancer driving gata2a expression in endothelium (i4 enhancer) and showed that Gata2a is required for HE programming by regulating expression of gata2b and runx1. By 5 days, homozygous gata2a
Introduction
Haematopoietic stem cells (HSCs) are the source of all blood produced throughout the lifetime of an organism. They are capable of self-renewal and differentiation into progenitor cells that generate specialised blood cell types. DNA-binding transcription factors are fundamental players in the inception of the haematopoietic system as it develops in the embryo, but also play a crucial role in maintaining homeostasis of the haematopoietic system in the adult organism. They are part of elaborate gene regulatory networks that coordinate differentiation, proliferation and survival of haematopoietic cells and ensure their levels are appropriate at all times throughout life. The only time during ontogenesis when HSCs are generated de novo is during embryonic development and misexpression of key transcription factors may lead to a catastrophic failure to produce HSCs or, alternatively, to haematopoietic disorders and eventually leukaemia. Therefore, understanding how transcription factors drive the haematopoietic process holds great clinical promise as it provides opportunities for intervention when haematopoiesis is dysregulated.
The development of blood occurs in distinct waves: primitive, pro-definitive and definitive, each of them characterised by the generation of blood progenitors in a specific location and restricted in time, where the definitive wave produces multi-lineage self-renewing HSCs (Ciau-Uitz et al., 2014) .
The specification of HSCs initiates in cells with arterial characteristics and proceeds through an endothelial intermediate, termed the haemogenic endothelium (HE) (Gritz and Hirschi, 2016) . In zebrafish and other vertebrates, expression of runx1 in the floor of the dorsal aorta defines the bona fide HE population (Burns et al., 2002; Gering and Patient, 2005; Kalev-Zylinska et al., 2002; Swiers et al., 2013) . Haematopoietic stem and progenitor cells (HSPCs) emerge from the HE by a process termed endothelial-to-haematopoietic transition (EHT), both in zebrafish and in mice (Bertrand et al., 2010; Boisset et al., 2010; Eilken et al., 2009; Kissa and Herbomel, 2010; Lam et al., 2010) . They first arise at around 34 hours post fertilisation (hpf) from the HE in the ventral wall of the DA (Kissa et al., 2008) , the analogue of the mammalian AGM (Davidson and Zon, 2004) . After EHT, the HSCs enter the bloodstream through the posterior cardinal vein (PCV) (Kissa et al., 2008) to colonise the caudal haematopoietic tissue (CHT), the zebrafish equivalent of the mammalian foetal liver (Murayama et al., 2006) . Afterwards the HSCs migrate again within the bloodstream to colonise the kidney marrow (WKM) and thymus (Kissa et al., 2008) , the final niche for HSCs, equivalent to the bone marrow in mammals (Ciau-Uitz et al., 2014) .
Gata2 is a key haematopoietic transcription factor (TF) in development. Gata2 knockout mice are embryonic lethal and die by E10.5 (Tsai et al., 1994) . Conditional Gata2 knockout under the control of the endothelial VE-cad promoter abolished the generation of intra-aortic clusters (de Pater et al., 2013) , suggesting that Gata2 is required for HSPC formation. In addition, conditional deletion of Gata2 mediated by a Vav-Cre transgene demonstrated that Gata2 is also required for the maintenance and survival of HSCs in the foetal liver, after HE specification and HSC emergence (de Pater et al., 2013) . Further studies in the mouse revealed a decrease in HSC numbers in Gata2 heterozygous mutants, but also a dose-dependency of adult HSCs on Gata2 (Ling et al., 2004) . In humans, GATA2 haploinsufficiency leads to blood disorders, including MonoMAC syndrome (Monocytopenia, Mycobacterium avium complex) and myeloid dysplastic syndrome (MDS) Spinner et al., 2014) . While its presentation is variable, MonoMAC syndrome patients always show cytopenias, ranging from mild to severe, and hypocellular bone marrow (Wlodarski et al., 2017; Wlodarski et al., 2016) , highlighting the importance of maintaining Gata2 expression in adult haematopoietic cells. These patients are susceptible to mycobacterial and viral infections (Hsu et al., 2015) and have a propensity to develop myelodisplastic syndrome (MDS) and Acute Myeloid Leukaemia (AML), with a 75% prevalence and relatively early onset at age 20 (Wlodarski et al., 2017) .
Gata2 expression in the endothelium is regulated by an enhancer element located in its intron 4, termed the +9.5 enhancer (Gao et al., 2013; Khandekar et al., 2007) . Deletion of this enhancer results in the loss of HSPC emergence from HE, leading to lethality by E14 (Gao et al., 2013) . The same element is also mutated in 10% of all the MonoMAC syndrome patients .
Because of a whole genome duplication during the evolution of teleost fish, numerous zebrafish genes exist in the form of two paralogues, including gata2 (Gillis et al., 2009; Taylor et al., 2003; Taylor et al., 2001) . Gata2a and gata2b are only 57% identical and are thought to have undergone evolutionary sub-functionalisation from the ancestral vertebrate Gata2 gene (Butko et al., 2015; Liu et al., 2016) . This provides an opportunity to separately identify the temporally distinct contributions made by each Gata2 orthologue. gata2b is expressed in HE in the floor of the dorsal aorta from 18hpf and is required for runx1 expression in HE (Butko et al., 2015) . In addition, lineage tracing experiments showed that gata2b-expressing HE cells gave rise to HSCs in the adult (Butko et al., 2015) . Similar to the mouse Gata2, gata2b expression depends on Notch signalling (Butko et al., 2015) . Thus, gata2b is a bona fide marker of HE (Gao et al., 2016) and is currently regarded as the functional 'haematopoietic homologue' of Gata2 in zebrafish.
By contrast, gata2a is expressed in all endothelial cells and in the developing central nervous system (Butko et al., 2015; Yang et al., 2010) and gata2a um27 mutants showed arteriovenous shunts in the dorsal aorta at 48hpf (Zhu et al., 2011) . However, gata2a is expressed already at 11hpf in the haemangioblast population in the posterior lateral mesoderm (PLM) that gives rise to the arterial endothelial cells in the trunk (Patterson et al., 2007) . This is well before gata2b is expressed in HE, suggesting that gata2a might play a role in endothelial and HE programming and thus help to elucidate an earlier role for Gata2 in HSC development.
Here we show that the gata2a locus contains a conserved enhancer in its 4 th intron, corresponding to the described +9.5Kb enhancer in the mouse Gata2 locus (Gao et al., 2013; Johnson et al., 2012; Khandekar et al., 2007) 
Results
A region of open chromatin in intron 4 of the zebrafish gata2a locus is specific to endothelium and highly conserved
Analysis of the zebrafish gata2a locus revealed that one region within the fourth intron was conserved across other vertebrates, including mouse and human (Fig. 1A) . This region, which we termed 'i4 enhancer', corresponds to the endothelial +9.5 Gata2 enhancer identified previously in the mouse (Gao et al., 2013; Khandekar et al., 2007) and human (Johnson et al., 2012) . Notably, the gata2b locus did not show broad conservation in non-coding regions (Fig. S1A ).
To investigate whether the i4 element was an active enhancer, we performed ATAC-seq (Buenrostro et al., 2013) to identify open chromatin regions in endothelial cells (ECs) in zebrafish. We used the Tg(kdrl:GFP) transgenic line, in which GFP marks all endothelium (Jin et al., 2005 supported by a correlation analysis (Fig. S1D-F) . 78,026 peaks were found in common between replicates of the ATACseq in kdrl:GFP + cells (Fig. S1G) . 44,025 peaks were differentially expressed between the kdrl:GFP + and kdrl:GFP -fractions (Fig. S1H ). An analysis of known motifs at transcription start site (TSS)-specific peaks (2% of the total peaks) present in the kdrl:GFP + population revealed an enrichment for the ETS motif (Fig. S1H,I ). ETS factors are essential regulators of gene expression in endothelium (Meadows et al., 2011) . In addition, we performed gene ontology (GO) term analysis on the peaks showing >3-fold enrichment or depletion in ECs (Fig S1J-L) . As expected, non-ECs showed a broad range of GO terms whereas EC-enriched peaks were associated with terms like angiogenesis or
Differential peak analysis in the gata2a locus identified four differentially open sites within a 20kb genomic region (Fig. 1A) , including one peak in intron 4 corresponding to the predicted i4 enhancer.
It contained a core 150bp-long element that included several binding motifs for the Gata, E-box and Ets transcription factor families (Fig. 1A) . Although the positioning of the E-box site relative to the adjacent GATA site differs in zebrafish and mammals (Fig. 1A) , the necessary spacer distance of ~9bp between the two sites (Wozniak et al., 2008 ) is conserved. Thus, this site may be a target for transcriptional complexes containing an E-box-binding factor and a GATA family TF.
In summary, the intronic enhancer (i4) identified in the zebrafish gata2a locus is accessible to transposase in endothelial cells and contains highly conserved binding sites for key haematopoietic transcription factors, suggesting that genetic regulation of gata2a expression in zebrafish HE is a conserved feature of vertebrate gata2 genes.
The gata2a-i4 enhancer drives GFP expression in the endothelium, including the haemogenic endothelium
To investigate the activity of the gata2a-i4 enhancer in vivo, the conserved genomic 150bp region (Fig. 1A) , together with flanking ±500bp (gata2a-i4-1.1kb:GFP) or ±150bp (gata2a-i4-450bp:GFP) was cloned into a Tol2-based reporter E1b:GFP construct (Kawakami et al., 2004 ) and used to generate stable transgenic lines (Fig. S2) . The earliest activity of the enhancer was observed at the 14-somite stage (14ss), when gfp mRNA was detected in the PLM (Fig. S2A,B) . After 22hpf, the reporter signal was pan-endothelial ( Fig. 1B -C, S2C-I). Around 27hpf, higher intensities of GFP fluorescence and corresponding higher levels of gfp mRNA were visible in the floor of the DA (Fig. 1B-C showed stronger expression of the transgene (Fig. S2K) . At 25hpf, the expression of GFP protein and gfp mRNA overlapped completely in the endothelial cells of the DA (Fig. 1D-D'' ). Overall, these data confirm that the i4 enhancer is active in vivo at the correct time window and tissue to regulate definitive haematopoiesis. Importantly, an analogous pattern was observed in mouse embryos driving LacZ under the +9.5 enhancer (Khandekar et al., 2007) , suggesting functional conservation of the gata2a-i4 enhancer across vertebrates.
To further characterise the enhancer activity in vivo, the Tg(gata2a-i4-1.1kb:GFP) embryos were stained for gata2a mRNA and for GFP protein ( Fig. S2K-O ). We found a large overlap between gata2a + and GFP + cells at 30hpf in the DA, with a small proportion of GFP + cells that did not express gata2a mRNA (<5%, Fig. S2O ). This could suggest that some cells require activity of other endothelial enhancers to trigger transcription of gata2a or that gfp mRNA has a longer half-life than gata2a mRNA. Importantly, the GFP signal was absent in gata2a-expressing neural cells ( Fig. S2L-N) ,
indicating that the i4 enhancer is specifically active in (haemogenic) endothelial cells.
Next we examined the expression of the HE marker runx1 (Gering and Patient, 2005) in gata2a-i4-1.1kb:GFP embryos at 25hpf. At this stage, over 90% of runx1 + cells were GFP + ( Fig. 1E-F) .
We conclude that the GFP expression under the gata2a-i4 enhancer marks the majority of the HE population.
Deletion of the gata2a-i4 enhancer results in decreased expression of gata2a in the embryonic endothelium without affecting endothelial development Gata2a is expressed in early development in various tissues, including ectoderm, primitive erythrocytes, neural tissue and endothelial cells (Meng et al., 1997; Patterson et al., 2007; Yang et al., 2007) . To investigate whether the endothelial-specific expression of gata2a is required for definitive haematopoiesis, we deleted the conserved gata2a-i4 enhancer using CRISPR/Cas9 genome editing (Bassett et al., 2013) . We generated a deletion mutant lacking 231bp of the i4 enhancer ( Fig. S3A- Fig. 2A,B) . By contrast, gata2a expression in the neural tube appeared unaffected in the gata2a Δi4/Δi4 mutants ( Fig. 2A,B) . At this stage, expression of the pan-endothelial marker kdrl was indistinguishable between wild type and gata2a Δi4/Δi4 mutants (Fig. 2C,D) .
To verify these results, we crossed homozygous gata2a Δi4/Δi4 mutants to Tg(kdrl:GFP) transgenics and analysed vascular morphology. Gata2a Δi4/Δi4 embryos showed no gross vascular abnormalities at 48hpf as assessed by the expression of the Tg(kdrl:GFP) transgene (Fig. 2E,F) .
Next, we isolated endothelial cells from Tg(kdrl:GFP) and Tg(kdrl:GFP); gata2a Δi4/Δi4 embryos by FACS (Fig. 2G ) at 23hpf and 30hpf and confirmed that kdrl expression was unaffected in gata2a
Δi4/Δi4 embryos (Fig. S4A ). In addition, the qPCR analysis revealed significantly decreased levels of gata2a mRNA in the kdrl:GFP + ECs in 23hpf gata2a Δi4/Δi4 embryos compared to wild types (t=20.026, d.f.=5, p<0.001) (Fig. 2H ). At 30hpf this decrease was not statistically significant. However, this was likely due to a decrease in expression of gata2a in wild type ECs that appears to occur normally during development, while the mutant expression levels remained low (Fig. 2H ). Importantly, there was no difference in gata2a expression in the non-endothelial population (kdrl:GFP -cells) between wild type and gata2a Δi4/Δi4 mutants at either 23hpf or 30hpf (Fig. 2I ). Altogether, these data suggest that genomic deletion of the gata2a-i4 enhancer is sufficient to reduce expression of gata2a specifically in the endothelial tissue. This is in agreement with the reported reduction in Gata2 expression in the endothelium of mouse Gata2 +9.5 enhancer deletion mutants (Gao et al., 2013; Johnson et al., 2012) .
The previously described gata2a um27/um27 mutant showed arteriovenous shunts and reduced perfusion of the DA, detectable around 48hpf (Zhu et al., 2011) . However, gata2a Δi4/Δi4 embryos showed no gross vascular abnormalities at 48hpf. In addition, gata2a Δi4/Δi4 mutants and wild type embryos expressed similar levels of the endothelial markers kdrl, dld and dll4. (Fig. S4A-C) . By contrast, gata2a um27/um27 mutants showed reduced kdrl expression (Zhu et al., 2011) . Moreover, because the DA endothelium is specified normally, the reduction in gata2a expression in gata2a
mutants likely results from reduced transcription rather than reflecting a secondary phenotype due to an earlier loss of endothelial cells. We conclude that the morphological defects observed in gata2a um27/um27 mutants were likely a result of an earlier loss of gata2a in the haemangioblast, prior to the 14-somite stage where i4 enhancer activity was first detected (Fig. S2A,B) .
Deletion of the gata2a-i4 enhancer results in reduced expression of runx1 and gata2b at early stages of HE specification
To investigate a potential role of gata2a in HSC development, we compared the expression of runx1, the key marker of HE in zebrafish (Gering and Patient, 2005; Kalev-Zylinska et al., 2002) , in wild type and gata2a Δi4/Δi4 embryos. Quantitative in situ hybridization analysis (Dobrzycki et al., 2018) (Fig. 3D ), at the onset of its expression in HE (Wilkinson et al., 2009 ). Thus, deletion of the gata2a-i4 enhancer results in impaired runx1 expression in the early stages of HE programming, suggesting a previously unreported role of gata2a in definitive haematopoiesis. This correlates well with published data, where +9.5 -/-mouse AGM explants showed lower levels of Runx1 expression compared to +9.5 +/+ controls (Gao et al., 2013) , further supporting the critical evolutionary role of the intronic enhancer of Gata2 in HSC specification.
Loss of function experiments showed that Gata2b, another Gata2 paralogue in zebrafish, is an upstream regulator of runx1 expression in the HE (Butko et al., 2015) . Thus, we tested whether gata2a could act upstream of gata2b by measuring gata2b expression in gata2a Δi4/Δi4 embryos (Fig.3 E-G). Similarly to runx1, quantitation of the in situ hybridization signal showed that gata2b expression was decreased in gata2a Δi4/Δi4 embryos compared to wild type siblings at 28hpf (µwt=39, (Fig. 3H ). Taken together, these data suggest that endothelial expression of gata2a is required upstream of gata2b for the proper specification of HE, uncovering a previously unrecognized role for Gata2a in definitive haematopoiesis.
Expression of late markers of embryonic HSC activity is unaffected in gata2a Δi4/Δi4 mutants Strikingly, the qPCR analysis ( Fig. 3D ,H) showed that by 30hpf the expression of both runx1 and gata2b in kdrl:GFP + ; gata2a Δi4/Δi4 ECs was indistinguishable from wild type kdrl:GFP + ECs. Of note, the kdrl:GFP + population likely includes the kdrl + , runx1-expressing EMPs located in the caudal region (Bertrand et al., 2007) . This region was not included in the quantification of in situ hybridization but cannot be separated by sorting for kdrl:GFP + only and could thus explain the discrepancy between image quantification and qPCR. Alternatively, the recovery of gata2b expression by 30hpf detected by qPCR suggested that other regulators of gata2b might compensate for the lack of endothelial gata2a in gata2a Δi4/Δi4 mutants and thus lead to a recovery of the initial haematopoietic phenotype.
Thus, to further characterize the haematopoietic phenotype in the gata2a Δi4/Δi4 mutants, we tested whether expression of markers of haematopoietic activity in the embryo was affected from 48hpf onwards (Fig. 4) .
At 48hpf, the expression of runx1 in the DA showed no significant difference between gata2a
Δi4/Δi4 mutants and wild type controls (µwt=33.1, µmut=37.5) ( Fig. 4A-B ). These data suggest that the decrease of runx1 expression at early stages of HE programming in gata2a Δi4/Δi4 mutants is transient and recovers by 2dpf. Indeed, analysis of the HSPC marker cmyb (Kissa et al., 2008; Murayama et al., 2006) in the CHT at 4dpf showed no differences between gata2a Δi4/Δi4 and wild type larvae ( Fig. 4C-D ). Expression of the T-cell progenitor marker rag1 in the thymus (Willett et al., 1997) can be used to assess the output of HSPCs from the DA . While at 4dpf around half of the gata2a Δi4/Δi4 larvae showed reduced rag1 expression compared to wild type ( Fig. 4E ,F), this effect was absent at 5dpf ( Fig. 4G ,H).
These data suggested that HSPC activity was normal in gata2a Δi4/Δi4 mutants from 4dpf onwards. To further characterize this, we crossed the gata2a Δi4/Δi4 mutants to the Tg(itga2b:GFP;kdrl:mCherry)
transgenics, where itga2b-GFP high and itga2b-GFP low cells in the CHT mark thrombocytes and HSPCs, respectively (Kissa et al., 2008; Lin et al., 2005) . Our analysis revealed no difference in itga2b-GFP low HSPC or itga2b-GFP high thrombocyte numbers in the CHT region at 5dpf between wild type and
Taken together, our data suggest that endothelial gata2a expression mediated by the i4 enhancer is required for the initial expression of gata2b and runx1 in the HE but largely dispensable after 2dpf.
Haematopoietic recovery of gata2a Δi4/Δi4 mutants is mediated by the Notch-gata2b pathway
We hypothesized that the recovery, not observed in +9.5 -/-mouse mutants (Gao et al., 2013) , could be due to the presence of two Gata2 orthologues in zebrafish, where gata2a is an upstream regulator of gata2b expression. Gata2b is crucial for HE specification and HSPC emergence (Butko et al., 2015) and our qRT-PCR data from sorted kdrl:GFP + cells suggested that its expression in gata2a Δi4/Δi4 mutants recovered by 30hpf (see Fig. 3H ). Therefore, we investigated whether the loss of gata2b in gata2a Δi4/Δi4 background resulted in a more severe haematopoietic phenotype than observed in the gata2a Δi4/Δi4 mutants. For this, we injected gata2a Δi4/Δi4 and wild type controls with a sub-optimal amount (7.5ng) of a gata2b morpholino oligonucleotide (MO) (Butko et al., 2015) .
Quantitative in situ hybridization analysis (Dobrzycki et al., 2018) showed that this amount of gata2b MO had no effect on runx1 expression at 32hpf (µwt=41.9, µMO=40.1; n.s., Welch's ANOVA) (Fig. 5A,B ).
In agreement with the previously observed effect on runx1 expression in gata2a Δi4/Δi4 embryos, we observed a significant reduction compared to wild type siblings (µwt=41.9, µmut=28.9; F=44.641, d.f.=3, 62.3; p<0.001) (Fig. 5A,B) . However, sub-optimal gata2b knockdown in gata2a Δi4/Δi4 embryos further significantly reduced levels of runx1 expression (µmut=28.9, µmut+MO=17.2; p<0.001) (Fig. 5A,B ).
To test whether this stronger reduction of runx1 at 32hpf affected later stages of embryonic haematopoiesis, we assessed cmyb expression in the CHT at 4dpf (Fig. 5C (Fig. 5C ).
To verify that Gata2b is required for definitive haematopoiesis downstream of Gata2a, we generated a frameshift truncating mutant for Gata2b. Next we incrossed gata2a Δi4/+ ; gata2b +/-adults and investigated cmyb expression at 33hpf in their progeny. Both single mutants showed reduced levels of cmyb expression in the trunk (Fig S5A-D) , suggesting that all gata2 alleles are important for HSPC generation at this stage. In the absence of Gata2b, Gata2a was not sufficient to drive cmyb expression in HE, because gata2a +/+ ; gata2b -/-; embryos showed no further reduction in cmyb expression when compared with gata2b -/-; gata2a Δi4/Δi4 (Fig. S5A-D) . Thus, we conclude that Gata2b is required for definitive haematopoiesis and its expression is regulated by Gata2a.
Next, we tested whether forced ectopic expression of gata2b was sufficient to speed up the (Fig. 5D ). Importantly, it was sufficient to bring the runx1 expression levels in the mutants up to the levels detected in uninjected wild type fish (µwt=38.8, µmut+gata2b=33.2; n.s.) (Fig. 5D ), suggesting that gata2b alone was sufficient to drive runx1 expression in ventral wall of the DA and drive the haematopoietic recovery in gata2a Δi4/Δi4 mutants. Thus, pan-endothelial gata2b can recover the definitive haematopoietic programme even in the absence of endothelial gata2a.
Because the expression of gata2b is regulated by Notch signalling (Butko et al., 2015) , we investigated whether inhibition of Notch would also prevent the haematopoietic recovery of gata2a Δi4/Δi4 embryos. For this, we used the Notch inhibitor DAPM (Walsh et al., 2002) , and titrated it down to a sub-optimal dose (25µM) that did not affect runx1 expression in treated embryos (Fig. 5E ).
Next, we treated wild type and gata2a Δi4/Δi4 mutant embryos with the sub-optimal dose of DAPM and measured runx1 expression in the DA at 36hpf (Fig. 5E,F) . As expected, the DAPM treatment did not affect the expression of runx1 in the wild type embryos (µDMSO=40.5, µDAPM=38; n.s.) (Fig. 5E,F conclude that HE programming requires two independent inputs on gata2b expression; one from Gata2a, driven in ECs by the i4 enhancer, and the other from Notch signalling, necessary and sufficient to drive HE programming even in the absence of gata2a (Fig. 5E ).
Adult gata2a Δi4/Δi4 mutants suffer from defects resembling GATA2 haploinsufficiency
Although the expression of haematopoietic markers recovers in the gata2a Δi4/Δi4 embryos due to Notch-gata2b activity, these mutants may have long term effects, particularly if Gata2a and Gata2b
could not fully compensate for each other in adult haematopoiesis. Consistent with this notion, we observed a high incidence of infections and heart oedemas in gata2a Δi4/Δi4 adult fish, with over 25%
suffering from one of these defects by 6 months of age, compared to <1% of wild type fish ( Fig. 6A-C ). The heart oedemas point to an additional function of the gata2a-i4 enhancer in the heart or the lymphatic system, while the infections may suggest immune defects, as observed in human patients that bear genetic GATA2 haploinsufficiency syndromes like Emberger's or MonoMAC syndrome (Spinner et al., 2014) . Around 10% of MonoMAC syndrome patients show mutations in the homologous enhancer region of GATA2 Wlodarski et al., 2016) . Therefore, to investigate whether the phenotype in adult gata2a Δi4/Δi4 mutants resembled human Gata2 haploinsufficiency in humans, we first asked whether the gata2a-i4-1.1kb:GFP reporter was active in haematopoietic cells in the adult. Whole kidney marrow (WKM) cells isolated from the transgenic fish showed that the i4 enhancer is active in haematopoietic cells previously defined by flow cytometry (Traver et al., 2003) as progenitors, lymphoid+HSPC (containing the HSPCs) and myeloid cells (Fig S6A-C) ). Accordingly, single cell transcriptional profiling showed higher levels of gata2a in HSPCs, progenitors, neutrophils and thrombocytes ( Fig. S6D-F) (Athanasiadis et al., 2017; Macaulay et al., 2016) .
Next, we counted the total number of haematopoietic cells in the WKM of wild types and gata2a Δi4/Δi4 mutants (Fig 6D-F (Fig. 6D-F) . In addition, the numbers of neutrophils were similarly reduced (µwt=2.17x10 5 ;µmut=1.03x10 5 , p=0.0269, Mann-Whitney test) (Fig. 6G) , another characteristic phenotype of MonoMAC syndrome patients (Wlodarski et al., 2016) . Lastly, cytology of kidney marrow smears of three 9-month old gata2a Δi4/Δi4 mutants were assessed. A clear AML was detected in one of the three mutants, with 98% blasts and only minor erythrocyte differentiation in the WKM (Fig. 6H,I ). Together these data strongly suggest that the i4 enhancer is a critical driver of gata2a expression in adult haematopoietic cells. Loss of gata2a expression in gata2a Δi4/Δi4 mutants leads to a hypocellular WKM and neutropenia, strongly suggestive of marrow failure that can progress to AML, a hallmark of disease progression in MonoMAC syndrome patients.
Discussion
Endothelial expression of gata2a through a conserved intronic enhancer is required for HE programming Gata2 is critically required for the generation and maintenance of embryonic HSCs (de Pater et al., 2013; Tsai et al., 1994) . Expression of Gata2 in the haemogenic endothelium (HE) and its subsequent role in the specification of the HSCs depends on its intronic enhancer, termed the VE enhancer (Khandekar et al., 2007) or +9.5 enhancer (Gao et al., 2013) . The homologous region in humans was also correlated with susceptibility to blood-related disorders (Johnson et al., 2012 ). Here we have investigated the conservation of this enhancer and identified a homologous region in intron 4 of the zebrafish gata2a locus (gata2a-i4) that is not present in the gata2b locus. The sub-functionalisation of the Gata2 paralogues in zebrafish provided an opportunity to unpick the different roles of Gata2 in the multi-step process of definitive haematopoiesis. The zebrafish gata2a-i4 enhancer contains multiple conserved transcription factor binding sites and, like the mouse VE enhancer (Khandekar et al., 2007) , is sufficient to drive pan-endothelial expression of GFP and necessary for endothelial expression of gata2a (Fig. 1,2) . We traced the activity of the i4 enhancer back to the PLM, the source of precursors of endothelium and HSCs (Davidson and Zon, 2004; Medvinsky et al., 2011) . This degree of sequence and functional conservation of the i4 enhancer led us to hypothesize that Gata2a might play a role in definitive haematopoiesis. Indeed, homozygous deletion of the i4 enhancer (gata2a
Δi4/Δi4
) allowed us to uncover a previously unknown function of Gata2a in regulating expression of its paralogue gata2b in HE. Runx1, a target of Gata2b (Butko et al., 2015) that is critical for the EHT process (Kissa and Herbomel, 2010) , was also reduced in gata2a Δi4/Δi4 mutants, suggesting that a novel Gata2a/Gata2b/Runx1 axis regulates gene expression in the HE, before the first reported EHT events at 34hpf (Kissa and Herbomel, 2010) .
Regulation of gata2a and gata2b
Gata2 is thought to bind to the +9.5 enhancer to maintain its own expression in endothelial and haematopoietic cells (Johnson et al., 2012; Sanalkumar et al., 2014) . In zebrafish, it is likely that Gata2a binds the GATA motifs in the i4 enhancer and loss of gata2a in the endothelium of gata2a Δi4/Δi4 mutants (Fig. 2) seems to support this view. Interestingly, we detected a small region in intron 4 of the gata2b locus that was not identified as a peak in our ATACseq experiment but is conserved in some fish species (Fig. S1A ) and thus could potentially represent a divergent gata2b intronic enhancer. We speculate that the positive autoregulation of Gata2 was likely retained by both gata2 orthologues in zebrafish. In this case, Gata2a would bind to the gata2b intronic enhancer in HE only until enough Gata2b is present, at which point its intronic enhancer would 'switch' Gata2a for Gata2b to maintain gata2b expression. This 'switch', however, would replace one activator for another, rather than replacing an activating Gata factor (Gata2) for a repressive Gata factor as described previously for the Gata2/Gata1 switch in erythroid cells (Grass et al., 2006) . Alternatively, the positive auto-regulation function might have been modified in HE so that Gata2a binds to both gata2a and gata2b intronic enhancers to regulate their expression. These possibilities remain to be investigated.
Rescue of the haematopoietic defects in gata2a
Δi4/Δi4 mutants
The gata2a
Δi4/Δi4 mutants recovered from the early defects in HE programming and displayed normal expression levels of cmyb in the CHT at 4dpf and rag1 in the thymus at 5dpf, used as indicators of the definitive haematopoietic programme (Murayama et al., 2006) . We hypothesized that this could be due to the presence of the two homologues of Gata2 in zebrafish (Gillis et al., 2009) , despite Gata2a
and Gata2b proteins being only 50% identical (Butko et al., 2015) . Indeed, forced expression of gata2b under the gata2a-i4 enhancer rescued the expression of runx1 in the gata2a Δi4/Δi4 mutants to wild type levels and sub-optimal depletion of gata2b in the gata2a Δi4/Δi4 mutants resulted in more severe reduction in runx1 and cmyb expression in the CHT by 4dpf (Fig.4) . In addition, we demonstrated that Notch signalling, a known regulator of gata2b expression (Butko et al., 2015) , is sufficient to rescue the initial HE programming defect induced by deletion of the gata2a-i4 enhancer.
We propose a model in which gata2a acts upstream of gata2b and independently of Notch to initiate HE programming. In this context, Notch signalling functions as a fail-safe mechanism that buffers against fluctuations in the system caused by loss of one or more of the initial inputs (in this case, Gata2a).
Gata3 is also expressed in ECs prior to HSC emergence (Fitch et al., 2012) and could contribute towards the haematopoietic recovery in gata2a Δi4/Δi4 mutants. However, distinguishing its non-cell autonomous role in the production of catecholamines (Fitch et al., 2012 ) from a putative role in endothelium would require tissue-specific inactivation of Gata3 using a Cre-lox system or by deleting endothelial-specific enhancers as we did for the gata2a-i4 enhancer. There are very few examples reported to date and, to our knowledge, only one in the zebrafish model (Chiang et al., 2017) .
In the mouse, two different studies showed that mouse +9.5 -/-enhancer mutants exhibit decreased haematopoietic output from cultured AGM explants (Gao et al., 2013) or foetal liver HSCs (Johnson et al., 2012) . However, in both cases the experiments were performed at E11.5, well after the HE had been established and given rise to HSCs (Swiers et al., 2013) . Furthermore, at E11.5 the numbers of haematopoietic cells in the AGM were roughly comparable to their wild type siblings (Gao et al., 2013; Johnson et al., 2012) , raising the possibility that an initial HE defect might have gone unnoticed in those studies. Thus, by analysing the contribution of two zebrafish Gata2 paralogues, we uncovered a previously unappreciated contribution by a Gata2 gene in the programming of HE prior to HSC specification.
Loss of i4 enhancer activity leads to a Gata2 haploinsufficiency phenotype similar to the human

MonoMAC syndrome
Although the gata2a Δi4/Δi4 embryos showed an apparent haematopoietic recovery by 5dpf, we observed a high incidence of infections and oedema in gata2a Δi4/Δi4 adults, and a striking decrease in the number of haematopoietic cells in the WKM. The decrease in haematopoietic cells in particular is reminiscent of the loss of proliferative potential of haematopoietic Gata2 +/-heterozygous cells in the mouse (Ling et al., 2004; Rodrigues et al., 2005) . This raises the possibility that in zebrafish the gata2a and gata2b paralogues may function as two Gata2 'alleles' that together regulate the haematopoietic output of the WKM. This will be addressed by comparing the adult phenotypes of gata2a Δi4/Δi4 and gata2b -/-mutants.
Taken together, our initial characterization of WKM suggests that gata2a Δi4/Δi4 mutants present a phenotype consistent with that of MonoMAC syndrome patients Johnson et al., 2012) . Strikingly, about 10% of all MonoMAC patients show mutations in the conserved +9.5
enhancer Wlodarski et al., 2016) , the corresponding regulatory element to the i4 enhancer. The i4 enhancer is active in the lymphoid+HSPC fraction that contains the HSC activity (Ma et al., 2011) , in the progenitor cells and in the myeloid fraction that contains monocytes and other myeloid cells including the eosinophils, previously identified as expressing high levels of a gata2a-GFP BAC transgenic reporter (Traver et al., 2003) . Similarly, runx1 W84X/W84X mutants that recovered definitive haematopoiesis despite the lack of runx1, showed a decrease in the total number of blood cells in the WKM, especially myeloid and progenitor cells (Sood et al., 2010) . This suggests lineage-specific differentiation defects, which are likely present in the gata2a Δi4/Δi4 adult fish.
In MonoMAC patients, the mononuclear cells (dendritic cells, monocytes, B and Natural Killer lymphocytes) are frequently affected (Collin et al., 2015) . Further characterization of the gata2a n=17, gata2a Δi4/Δi4 + gata2a-i4-450bp:gata2b construct) Error bars: mean±SD. **p<0.01; ***p<0.001.
(E) Quantification of the runx1 in situ hybridization signal at 36hpf in embryos treated with a suboptimal dose (25µM) of the Notch inhibitor DAPM. 25 µM DAPM showed no effect on runx1 expression in wild type (red squares) compared to DMSO-treated embryos (blue circles). As expected, DMSO-treated gata2a Δi4/Δi4 mutants (red triangles) show a decrease in runx1 expression whereas the DAPM treatment (yellow squares) significantly reduced runx1 expression in the DA gata2a Δi4/Δi4 mutants. (n=27, wild type+ DMSO; n=20, gata2a 
Methods
Maintenance of zebrafish
Zebrafish (Danio rerio) were maintained in flowing system water at 28.5°C, conductance 450-550μS and pH 7.0±0.5 as described (Westerfield, 2007) . Fish suffering from infections or heart oedemas were culled according to Schedule 1 of the Animals (Scientific Procedures) Act 1986. Eggs were collected by natural mating. Embryos were grown at 24-32°C in E3 medium with methylene blue and staged according to morphological features (Kimmel et al. 1995) corresponding to respective age in hours or days post fertilization (hpf or dpf, respectively). Published lines used in this work were wild type (wt KCL ) and Tg(kdrl:GFP) s843 (Jin et al. 2005) . All animal experiments were approved by the relevant University of Oxford, University of Birmingham and Erasmus University ethics committees.
ATAC-seq
Tg(kdrl:GFP) s843 embryos were dissociated for FACS at 26-27hpf to collect kdrl + and kdrl -cell populations (40,000-50,000 cells each). They were processed for ATAC library preparation using optimised standard protocol (Buenrostro et al., 2013) . Briefly, after sorting into Hanks' solution were checked for base qualities, trimmed where 20% of the bases were below quality score 20, and filtered to exclude adapters using Trimmomatic (Version 0.32) and mapped to Zv9 reference genome (comprising 14,612 genes) (Howe et al., 2013) using STAR with default parameters. The results were visualised using UCSC Genome Browser (http://genome-euro.ucsc.edu/) (Kent et al., 2002 Generation of transgenic Tg(gata2a-i4:GFP) and mutant gata2a ∆i4/∆i4 and gata2b -/-zebrafish lines Genomic regions containing the identified 150bp-long gata2a-i4 enhancer flanked by ±500bp (i4-1.1kb) or ±150bp (i4-450bp) were amplified from wild type zebrafish genomic DNA with NEB Phusion ® polymerase (see Table S1 for primer sequences) and cloned upstream of E1b minimal promoter and GFP into a Tol2 recombination vector (Addgene plasmid #37845, (Birnbaum et al., 2012) ) with Gateway ® cloning technology (Life Technologies™) following the manufacturer's protocol.
One-cell zebrafish embryos were injected with 1nl of an injection mix, containing 50pg gata2a-i4-E1b-GFP-Tol2 construct DNA + 30pg tol2 transposase mRNA (Kawakami et al., 2004) . Transgenic founders (Tg(gata2a-i4:GFP)) were selected under a widefield fluorescent microscope and outbred to wt fish. Carriers of monoallelic insertions were detected by the Mendelian distribution of 50% fluorescent offspring coming from wt outcrosses. These transgenics were then inbred to homozygosity.
To generate the i4 deletion mutant, we identified potential sgRNA target sites flanking the 150bp conserved region within intron 4 of the gata2a locus (see Fig. 1A , Fig S3A) . sgRNAs were designed with the CRISPR design tool (http:/crispr.mit.edu/, see Table S1 for sequences) and prepared as described (Bassett et al., 2013) . To reduce potential off-target effects of CRISPR/Cas9, we utilized the D10A 'nickase' version of Cas9 nuclease (Mali et al., 2013; Ran et al., 2013) , together with two pairs of sgRNAs flanking the enhancer (Table S1 , Fig. S3A-B) . We isolated two mutant alleles with deletions of 215bp (Δ78-292) and 231bp (Δ73-303) (Fig. S3B ). Both deletions included the highly conserved Ebox, Ets and GATA transcription factor binding sites (Fig. S3B) . The Δ73-303 allele was selected for further experiments and named Δi4. Adult zebrafish were viable and fertile as heterozygous (gata2a ∆i4/+ ) or homozygous (gata2a
). To unambiguously genotype wild types, heterozygotes and homozygous mutants, we designed a strategy consisting of two PCR primer pairs (Fig. S3A, C) .
One primer pair flanked the whole region, producing a 600bp wild type band and 369bp mutant band. In the second primer pair, one of the primers was designed to bind within the deleted region, only giving a 367bp band in the presence of the wild type allele (Fig. S3C) .
To generate the gata2b mutant we designed a CRISPR/Cas9 strategy for a frameshift truncating mutant in exon 3 deleting both zinc fingers. sgRNAs were designed as described above and guides were prepared according to Gagnon et al. (Gagnon et al., 2014) with minor adjustments. Guide RNAs were generated using the Agilent SureGuide gRNA Synthesis Kit, and guide were allowed to form ribonucleoprotein structures (RNPs) at RT and injected in 1 cell stage oocytes. 8 embryos were selected at 24 hpf and lysed for DNA isolation. Heteroduplex PCR analysis was performed to test guide functionality and the other embryos from the injection were allowed to grow up. To aid future genotyping we selected mutants by screening F1 for a PCR detectable integration or deletion in exon 3. Sequence verification showed that founder 3 had a 28 nt integration resulting in a frameshift truncating mutation leading to 3 new STOP codons in the third exon. To get rid of additional mutations caused by potential off target effects, founder 3 was crossed to WT for at least 3 generations. All experiments were performed with offspring of founder 3.
Fluorescence-activated cell sorting (FACS)
~100 embryos at the required stage were collected in Low Binding ® SafeSeal ® Microcentrifuge Tubes (Sorenson) and pre-homogenized by pipetting up and down in 500µl Deyolking Buffer (116mM NaCl, 2.9mM KCl, 5mM HEPES, 1mM EDTA). They were spun down for 1min. at 500g and incubated for Table S1 ). Table S3 for the details of TaqMan ® assays). The reaction was incubated for 15min. at 50°C, for 2min. at 95°C and amplified for 20 cycles of 15s at 95°C/4min. at 60°C. The cDNA was diluted 1:5 in TE buffer and stored at -20°C.
Diluted cDNA was used for qRT-PCR according to the Fluidigm protocol for Gene Expression with the 48.48 IFC Using Standard TaqMan ® Assays (Table S3) . Each sample was run in 3-4 biological replicates.
The collected data were analysed with Fluidigm Real-Time PCR Analysis software (version 4.1.3). The baseline was automatically corrected using the built-in Linear Baseline Correction. The thresholds were manually adjusted for each gene to fall within the linear phase of exponential amplification, after which they were set to equal values for the housekeeping genes: rplp0, rpl13a, cops2 (Xu et al., 2016) , lsm12b (Hu et al., 2016) 
Flow cytometry and isolation of WKM haematopoietic cells
Single cell suspensions of WKM cells were prepared from adult zebrafish kidneys of the required genotypes as described (Stachura and Traver, 2016) . Flow cytometry analysis was performed on a FACS Aria II (BD Biosciences) after exclusion of dead cells by uptake of Hoechst dye (Hoechst 33342, H3570, ThermoScientific), as described (Traver et al., 2003) . WKM cell counts were performed on a PENTRA ES60 (Hariba Medical) following the manufacturer's instructions. Note that the cell counter does not recognize the zebrafish nucleated erythrocytes, so these were excluded from this analysis.
Cell counts for each genotype were analysed with 2-tailed paired-samples t-tests with 95%
confidence levels, using a Mann-Whitney test for non-parametric distribution. The scatter plots were generated using GraphPad Prism 7 and show medians±SD.
May-Grunwald and Wright-Giemsa staining
Cell staining with May-Grunwald (MG) stain (Sigma MG500) and Giemsa (GIEMSA STAIN, FLUKA 48900) was performed on haematopoietic cell samples. After cytospin, slides are allowed to air-dry and were stained for 5 min at room temperature with a 1:1 mix of MG:distilled water. Next, slides were drained and stained with a 1:9 dilution of Giemsa:distilled water solution for 30min at room temperature. Excess solution was drained and removed by further washes in distilled water. Finally, the slides were air-dried and mounted in DPX (06522, Sigma) for imaging.
Whole mount in situ hybridization (ISH) and immunohistochemistry
Whole-mount ISH was carried out as described previously (Jowett and Yan, 1996) , using probes for kdrl, runx1, cmyb, gata2a , gata2b, rag1 (Kalev-Zylinska et al., 2002; Monteiro et al., 2016; Thompson et al., 1998; Willett et al., 1997) , and gfp (Table S1 ). For conventional ISH embryos were processed, imaged and the ISH signal quantified as described (Dobrzycki et al., 2018) . Briefly, the pixel intensity values were assessed for normal distribution with a Q-Q plot and transformed when necessary. Mean values (µ) of each experimental group were analysed with 2-tailed independent-samples t-tests or with ANOVA with 95% confidence levels, testing for the equality of variances with a Levene's test and applying the Welch correction when necessary. For ANOVA, differences between each two groups were assessed with either Tukey's post-hoc test (for equal variances) or with Games-Howell test (for unequal variances). For all these analyses, the IBM ® SPSS ® Statistics (version 22) or GraphPad Prism 8.0 package were used.
For the analysis of cmyb expression in the CHT at 4dpf, the embryos scored as 'high' or 'low' were tested for equal distribution between morphants and uninjected controls or among wild type, heterozygous and mutant genotypes with contingency Chi-squared tests, applying Continuity
Correction for 2x2 tables, using IBM ® SPSS ® Statistics (version 22).
For fluorescent ISH (FISH) combined with immunohistochemistry, ISH was performed first following the general whole mount in situ hybridisation protocol. The signal was developed with SIGMAFAST Fast Red TR/Naphthol, the embryos rinsed in phosphate-buffered saline with tween20 (PBT) and directly processed for immunohistochemistry. Embryos were blocked in blocking buffer (5 % goat serum/0.3 % Triton X-100 in PBT) for 1 hour at RT before incubated with primary antibody against GFP (rabbit, 1:500, Molecular Probes), diluted in blocking buffer overnight at 4°C. Secondary antibody raised in goat coupled to AlexaFluor488 (Invitrogen) was used in 1:500 dilutions for 3h at RT. Hoechst 33342 was used as a nuclear counterstain.
Fluorescent images were taken on a Zeiss LSM880 confocal microscope using 40x or 63x oil immersion objectives. Images were processed using the ZEN software (Zeiss).
Widefield fluorescence microscopy
For widefield fluorescence microscopy, live embryos were anaesthetised with 160 μg/ml MS222 and mounted in 3% methylcellulose and imaged on a AxioLumar V.12 stereomicroscope (Zeiss) equipped with a Zeiss AxioCam MrM.
Counting of itga2b-GFP high and itga2b-GFP low cells
To count itga2b-GFP high and itga2b-GFP low cells in the CHT, Tg(itga2b:GFP;kdrl:mCherry); gata2a
Δi4/+ animals were incrossed and grown in E3 medium supplemented with PTU to prevent pigment formation. At 5dpf, the larvae were anaesthetised with MS222 and the tail was cut and fixed for 1h
at room temperature in 4% PFA. Next, the tails were mounted on 35 mm glass bottomed dishes (MAtTEK) in 1 % low melt agarose and imaged using a 40x oil objective on an LSM880 confocal microscope (Zeiss). Cells in the CHT region were counted manually on Z-stacks as 'itga2b:GFP 
